Anna Mitus

Last updated

Anna Mitus was a medical researcher best known for her work on the measles vaccine as a part of the John Enders lab. Her most significant contribution to the research was her research on human amnion cells with Dr. Milan V. Milovanovic and how they supported the growth of the measles virus.

Contents

Work on the measles vaccine

In 1957, with Dr. Milan V. Milovanovic and John Enders, Anna Mitus published their research “Cultivation of Measles Virus in Human Amnion Cells and in Developing Chick Embryo”. [1] It was published in the journal of Experimental Biology and Medicine. [2] In this research, the team was able to propagate the measles virus throughout 28 serial passages in human amnion cells. After the 28th passage in human amnion cells, the measles virus was then inoculated into chick embryos. This procedure was key because no viral activity inside of an egg had yet been detected at this point.

In 1959, Mitus was the lead author of an article entitled “Persistence of Measles Virus and Depression of Antibody Formation in Patients with Giant-Cell Pneumonia after Measles” published in The New England Journal of Medicine. She collaborated with John F. Enders, John M. Craig and Ann Holloway. The main conclusion from this paper was that in a proportion of giant-cell pneumonia cases, the measles virus was found to be an etiologic agent. [3]

Overall, Mitus published at least 9 peer-reviewed journal articles on measles and the measles virus.

On October 1, 1961, John Enders wrote a letter to the editor of the New York Times in which he made sure that his six other lab members received just as much credit as him saying “To me it seems most desirable that the collaborative character of these investigations should be understood, not solely for personal reasons but because much of all modern medical research is conducted in this way.” [4]

Personal life

Mitus and her husband, Dr. W. Jack Mitus, immigrated to the United States in 1953. Anna Mitus became an Assistant Physician at Children's Hospital and Children's Cancer Research Center in Boston. [5] Her husband worked as a professor at Tufts University. Together they had two daughters; her daughter (A. Jacquline Mitus) became a doctor. [6]

Related Research Articles

<span class="mw-page-title-main">Vaccine</span> Pathogen-derived preparation that provides acquired immunity to an infectious disease

A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness of vaccines has been widely studied and verified. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and recognize further and destroy any of the microorganisms associated with that agent that it may encounter in the future.

<span class="mw-page-title-main">Measles</span> Viral disease affecting humans

Measles is a highly contagious, vaccine-preventable infectious disease caused by measles virus. Symptoms usually develop 10–12 days after exposure to an infected person and last 7–10 days. Initial symptoms typically include fever, often greater than 40 °C (104 °F), cough, runny nose, and inflamed eyes. Small white spots known as Koplik's spots may form inside the mouth two or three days after the start of symptoms. A red, flat rash which usually starts on the face and then spreads to the rest of the body typically begins three to five days after the start of symptoms. Common complications include diarrhea, middle ear infection (7%), and pneumonia (6%). These occur in part due to measles-induced immunosuppression. Less commonly seizures, blindness, or inflammation of the brain may occur. Other names include morbilli, rubeola, red measles, and English measles. Both rubella, also known as German measles, and roseola are different diseases caused by unrelated viruses.

<span class="mw-page-title-main">MMR vaccine</span> Any of several combined vaccines against measles, mumps, and rubella

The MMR vaccine is a vaccine against measles, mumps, and rubella, abbreviated as MMR. The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least four weeks between the doses. After two doses, 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella. The vaccine is also recommended for those who do not have evidence of immunity, those with well-controlled HIV/AIDS, and within 72 hours of exposure to measles among those who are incompletely immunized. It is given by injection.

<span class="mw-page-title-main">HIV vaccine development</span> In-progress vaccinations that may prevent or treat HIV infections

An HIV vaccine is a potential vaccine that could be either a preventive vaccine or a therapeutic vaccine, which means it would either protect individuals from being infected with HIV or treat HIV-infected individuals.

<span class="mw-page-title-main">John Franklin Enders</span> American medical researcher (1897-1985)

John Franklin Enders was an American biomedical scientist and Nobel Laureate. Enders has been called "The Father of Modern Vaccines."

<i>Measles morbillivirus</i> Species of virus

Measles morbillivirus(MeV), also called measles virus (MV), is a single-stranded, negative-sense, enveloped, non-segmented RNA virus of the genus Morbillivirus within the family Paramyxoviridae. It is the cause of measles. Humans are the natural hosts of the virus; no animal reservoirs are known to exist.

<span class="mw-page-title-main">Viral envelope</span> Outermost layer of many types of the infectious agent

A viral envelope is the outermost layer of many types of viruses. It protects the genetic material in their life cycle when traveling between host cells. Not all viruses have envelopes. A viral envelope protein or E protein is a protein in the envelope, which may be acquired by the capsid from an infected host cell.

<span class="mw-page-title-main">Mumps vaccine</span> Vaccine which prevents mumps

Mumps vaccines are vaccines which prevent mumps. When given to a majority of the population they decrease complications at the population level. Effectiveness when 90% of a population is vaccinated is estimated at 85%. Two doses are required for long term prevention. The initial dose is recommended between 12 and 18 months of age. The second dose is then typically given between two years and six years of age. Usage after exposure in those not already immune may be useful.

An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable. Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the pathogen.

The National Institute of Virology in Pune, India is an Indian virology research institute and part of the Indian Council of Medical Research (ICMR). It was previously known as 'Virus Research Centre' and was founded in collaboration with the Rockefeller Foundation. It has been designated as a WHO H5 reference laboratory for SE Asia region.

<span class="mw-page-title-main">Introduction to viruses</span> Non-technical introduction to viruses

A virus is a tiny infectious agent that reproduces inside the cells of living hosts. When infected, the host cell is forced to rapidly produce thousands of identical copies of the original virus. Unlike most living things, viruses do not have cells that divide; new viruses assemble in the infected host cell. But unlike simpler infectious agents like prions, they contain genes, which allow them to mutate and evolve. Over 4,800 species of viruses have been described in detail out of the millions in the environment. Their origin is unclear: some may have evolved from plasmids—pieces of DNA that can move between cells—while others may have evolved from bacteria.

<span class="mw-page-title-main">Chickenpox</span> Human viral disease

Chickenpox, or chicken pox, also known as varicella, is a highly contagious, vaccine-preventable disease caused by the initial infection with varicella zoster virus (VZV), a member of the herpesvirus family. The disease results in a characteristic skin rash that forms small, itchy blisters, which eventually scab over. It usually starts on the chest, back, and face. It then spreads to the rest of the body. The rash and other symptoms, such as fever, tiredness, and headaches, usually last five to seven days. Complications may occasionally include pneumonia, inflammation of the brain, and bacterial skin infections. The disease is usually more severe in adults than in children.

<span class="mw-page-title-main">Hemagglutinin</span>

In molecular biology, hemagglutinins are receptor-binding membrane fusion glycoproteins produced by viruses in the Paramyxoviridae family. Hemagglutinins are responsible for binding to receptors on red blood cells to initiate viral attachment and infection. The agglutination of red cells occurs when antibodies on one cell bind to those on others, causing amorphous aggregates of clumped cells.

<span class="mw-page-title-main">Rubella vaccine</span> Vaccine used to prevent rubella

Rubella vaccine is a vaccine used to prevent rubella. Effectiveness begins about two weeks after a single dose and around 95% of people become immune. Countries with high rates of immunization no longer see cases of rubella or congenital rubella syndrome. When there is a low level of childhood immunization in a population it is possible for rates of congenital rubella to increase as more women make it to child-bearing age without either vaccination or exposure to the disease. Therefore, it is important for more than 80% of people to be vaccinated. By introducing rubella containing vaccines, rubella has been eradicated in 81 nations, as of mid-2020.

Ann M. Arvin is an American pediatrician and microbiologist. She is the Lucile Salter Packard Professor of Pediatrics and Professor of Microbiology & Immunology Emerita at Stanford University. Arvin is a specialist of the Varicella zoster virus (VZV) and a prominent national figure in health. Arvin is currently the chief of the infectious diseases division of pediatrics at the Lucile Packard Children's Hospital, as well as the former Stanford's Vice Provost and Dean of Research.

<span class="mw-page-title-main">Chicken as biological research model</span> Use of the bird species for research on live beings

Chickens and their eggs have been used extensively as research models throughout the history of biology. Today they continue to serve as an important model for normal human biology as well as pathological disease processes.

<i>Cedillo v. Secretary of Health and Human Services</i> Legal case in United States Court of Federal Claims, decided February 12, 2009

Michelle Cedillo v. Secretary of Health and Human Services, also known as Cedillo, was a court case involving the family of Michelle Cedillo, an autistic girl whose parents sued the United States government because they believed that her autism was caused by her receipt of both the measles-mumps-and-rubella vaccine and thimerosal-containing vaccines. The case was a part of the Omnibus Autism Proceeding, where petitioners were required to present three test cases for each proposed mechanism by which vaccines had, according to them, caused their children's autism; Cedillo was the first such case for the MMR-and-thimerosal hypothesis.

<i>In ovo</i>

In ovo is Latin for in the egg. In medical usage it refers to the growth of live virus in chicken egg embryos for vaccine development for human use, as well as an effective method for vaccination of poultry against various Avian influenza and coronaviruses. During the incubation period, the virus replicates in the cells that make up the chorioallantoic membrane.

<span class="mw-page-title-main">Preben von Magnus</span>

Preben Christian Alexander von Magnus was a Danish virologist who is known for his research on influenza, polio vaccination and monkeypox. He gave his name to the Von Magnus phenomenon.

William Paul Duprex is a British scientist and advocate for vaccines and global health. He serves as Director of the University of Pittsburgh's Center for Vaccine Research and Regional Biocontainment Laboratory. Duprex holds the Jonas Salk Chair in Vaccine Research. He is also a professor of microbiology and molecular genetics at the University of Pittsburgh School of Medicine and serves as Editor-in-Chief of the Journal of General Virology, which is published by the Microbiology Society, and a senior editor of mSphere, published by the American Society for Microbiology. Duprex is an expert in measles and mumps viruses and studies viral spillover from animals to humans, including the SARS-CoV-2 virus that caused the COVID-19 pandemic. Duprex is a Fellow of the American Academy of Microbiology.

References

  1. Enders, J.F. (1991). Biographical Memoirs V.60. The National Academies Press. pp. 58–61. doi:10.17226/6061. ISBN   978-0-309-07865-8.
  2. Milovanovic, Milan V.; et al. (May 1957). "Cultivation of Measles Virus in Human Amnion Cells and in Developing Chick Embryo". Experimental Biology and Medicine. 95 (1): 120–127. doi:10.3181/00379727-95-23140. PMID   13432009. S2CID   33809113.
  3. Mitus, Anna; et al. (Oct 29, 1959). "Persistence of Measles Virus and Depression of Antibody Formation in Patients with Giant-Cell Pneumonia after Measles". The New England Journal of Medicine. 261 (18): 882–889. doi:10.1056/nejm195910292611802. PMID   14423063.
  4. Nicholas, Bakalar (October 4, 2010). "Measles Vaccine, 1960". The New York Times.
  5. Enders, J.F. (1991). Biographical Memoirs V.60. The National Academies Press. pp. 58–61. doi:10.17226/6061. ISBN   978-0-309-07865-8.
  6. Lawrence, J.M. (October 22, 2007). "Jack Mitus; trained generations of doctors". The Boston Globe.